ADENOSINE DE AMINASE ADA – (SERUM) at Dr. Essa Lab

ADENOSINE DE AMINASE ADA – (SERUM) at Dr. Essa Lab

The ADENOSINE DE AMINASE ADA – (SERUM) test at Dr. Essa Lab is a highly specialized, evidence-based biochemical assay used to measure the activity of the adenosine deaminase enzyme in the blood. Adenosine deaminase (ADA) is an essential polymorphic enzyme primarily involved in purine metabolism. It plays a critical role in cellular immunity, particularly in the proliferation, differentiation, and maturation of T-lymphocytes. By catalyzing the irreversible deamination of adenosine to inosine and deoxyadenosine to deoxyinosine, ADA prevents the toxic accumulation of intracellular metabolites, thereby safeguarding immune cell function. When the cell-mediated immune system is stimulated—such as during chronic infections, autoimmune flare-ups, or specific malignancies—T-lymphocytes release increased amounts of ADA into the extracellular space, leading to elevated levels in the serum. At Dr. Essa Lab, this test is executed using advanced automated chemistry platforms, providing clinicians with a highly sensitive surrogate marker of immune activation.

Understanding the clinical importance of the ADENOSINE DE AMINASE ADA – (SERUM) test is vital, especially in regions with a high burden of infectious diseases like Pakistan. While ADA activity is frequently measured in localized body fluids (such as pleural, peritoneal, or cerebrospinal fluid) to diagnose localized extrapulmonary tuberculosis, the serum ADA test offers a systemic overview of cell-mediated immune responses. It serves as an invaluable diagnostic aid in evaluating pulmonary tuberculosis, assessing liver parenchymal damage, investigating pyrexia of unknown origin (PUO), and monitoring autoimmune diseases. The diagnostic value of this test lies in its rapid turnaround time and cost-effectiveness, allowing healthcare providers to initiate timely therapeutic interventions while awaiting more time-consuming culture results. By choosing Dr. Essa Lab, patients benefit from a legacy of diagnostic excellence, ensuring that every serum sample is processed under stringent quality control protocols to deliver accurate and reliable clinical insights.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the clinical accuracy of the ADENOSINE DE AMINASE ADA – (SERUM) test. Patients are advised to adhere to the following preparation guidelines prior to sample collection:

• No Strict Fasting Required: Fasting is generally not mandatory for the serum ADA test. However, patients should consult their referring physician, especially if other concurrent blood tests are scheduled.
• Medication Disclosure: Patients must inform the laboratory staff and their physician about all ongoing medications, particularly immunosuppressants, corticosteroids, or anti-tuberculosis therapy (ATT), as these can alter lymphocyte activity and affect ADA levels.
• Avoid Alcohol Consumption: It is highly recommended to avoid alcohol consumption for at least 24 hours before the test, as alcohol can affect liver enzymes and potentially interfere with serum ADA measurements.
• Hydration: Maintaining adequate hydration by drinking water is encouraged, as it facilitates easier venous access during sample collection.
• Rest: Avoid strenuous physical exercise immediately before the blood draw to prevent transient physiological fluctuations in immune markers.

During the Procedure

The collection of the serum sample is a routine, safe, and standardized venipuncture procedure performed by certified phlebotomists at Dr. Essa Lab:

• Patient Identification and Verification: The phlebotomist will verify the patient’s identity and confirm compliance with any pre-test instructions.
• Positioning: The patient is comfortably seated, and the arm is positioned to expose the antecubital fossa.
• Site Selection and Sanitization: The phlebotomist identifies a suitable vein (typically the median cubital vein) and thoroughly cleanses the skin with an antiseptic swab (70% isopropyl alcohol) using a concentric motion. The site is allowed to air dry.
• Tourniquet Application: A tourniquet is applied a few inches above the selected site to increase venous pressure and make the vein more visible and palpable.
• Venipuncture: Using a sterile, single-use needle attached to a vacuum collection tube (typically a red-top clot activator tube or a gold-top serum separator tube), the phlebotomist gently inserts the needle into the vein.
• Sample Collection: Blood flows naturally into the tube. Once the required volume (approximately 3 to 5 mL) is collected, the tourniquet is released, and the needle is gently withdrawn.
• Post-Puncture Care: A sterile cotton ball or gauze is applied to the puncture site with gentle pressure to promote hemostasis. A bandage is then applied. The patient is advised to keep the bandage on for at least 1 to 2 hours.
• Sample Processing: The collected blood is allowed to clot at room temperature before undergoing centrifugation to separate the serum. The serum is then analyzed using advanced spectrophotometric or kinetic enzymatic assays. The entire collection process takes less than 10 minutes and is associated with minimal discomfort.

When is a ADENOSINE DE AMINASE ADA – (SERUM) Performed?

Suspected Pulmonary and Extrapulmonary Tuberculosis

Physicians frequently request the serum ADA test when evaluating patients with suspected pulmonary or extrapulmonary tuberculosis (TB), particularly in endemic regions. Tuberculosis triggers a robust cell-mediated immune response, leading to the proliferation of T-lymphocytes and a subsequent rise in serum ADA levels. Symptoms such as chronic cough, persistent low-grade fever, night sweats, unexplained weight loss, and fatigue warrant this investigation. The test assists in early screening and supports clinical decision-making alongside chest X-rays and sputum examinations.

Differential Diagnosis of Pyrexia of Unknown Origin (PUO)

Pyrexia of Unknown Origin (PUO) presents a significant diagnostic challenge to clinicians. When standard diagnostic investigations fail to identify the source of a prolonged fever, the serum ADA test is utilized as a biomarker of systemic immune activation. Elevated serum ADA levels point toward intracellular infectious etiologies, such as tuberculosis, brucellosis, typhoid fever, or deep-seated fungal infections, helping physicians narrow down the differential diagnosis and guide targeted secondary testing.

Evaluation of Hepatic Dysfunction and Liver Diseases

Because adenosine deaminase is highly active in liver parenchymal cells, the serum ADA test is performed to assess liver health. Hepatocyte damage caused by acute or chronic viral hepatitis, toxic liver injury, or cirrhosis results in the leakage of the enzyme into the bloodstream. Clinicians order this test to evaluate patients presenting with jaundice, abdominal pain, hepatomegaly, or abnormal liver function tests (LFTs), as serum ADA levels correlate closely with the severity of inflammatory activity in the liver.

Assessment of Autoimmune and Connective Tissue Disorders

Autoimmune diseases are characterized by chronic, dysregulated immune responses and persistent T-cell activation. The serum ADA test is performed to monitor disease activity in conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and sarcoidosis. Patients experiencing joint pain, systemic inflammation, skin rashes, or multi-organ involvement may undergo this test to help clinicians gauge the intensity of the inflammatory process and evaluate the patient’s response to immunosuppressive therapies.

Monitoring of Immunodeficiency States and Lymphoproliferative Diseases

The serum ADA test is clinically indicated in the investigation of hematological malignancies and immunodeficiency disorders. Markedly elevated serum ADA levels are observed in lymphoproliferative disorders, such as acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and various lymphomas, where rapid lymphocyte turnover occurs. Conversely, a congenital absence or severe deficiency of the ADA enzyme is the primary cause of Severe Combined Immunodeficiency (SCID). Testing is crucial in pediatric cases presenting with recurrent, life-threatening opportunistic infections to detect underlying genetic immunodeficiencies.

What Does a ADENOSINE DE AMINASE ADA – (SERUM) Detect?

The ADENOSINE DE AMINASE ADA – (SERUM) test is a highly sensitive indicator of cell-mediated immune activation and tissue turnover. Elevated or abnormal levels of serum ADA can detect, support the diagnosis of, or monitor the following clinical conditions:

• Active Pulmonary Tuberculosis
• Extrapulmonary Tuberculosis (miliary, lymph node, or skeletal TB)
• Tuberculous Pleurisy and Peritonitis (when correlated with fluid analysis)
• Acute Viral Hepatitis (Hepatitis A, B, C, or E)
• Chronic Active Hepatitis
• Decompensated and Compensated Liver Cirrhosis
• Toxic and Drug-Induced Liver Injury
• Autoimmune Hepatitis
• Rheumatoid Arthritis (RA)
• Systemic Lupus Erythematosus (SLE)
• Sarcoidosis
• Typhoid Fever (Enteric Fever)
• Infectious Mononucleosis (Epstein-Barr Virus infection)
• Brucellosis
• Leishmaniasis
• Acute Lymphoblastic Leukemia (ALL)
• Chronic Lymphocytic Leukemia (CLL)
• Hodgkin’s and Non-Hodgkin’s Lymphoma
• Multiple Myeloma
• Severe Combined Immunodeficiency (SCID) due to congenital ADA deficiency (detected as extremely low or absent levels)
• Celiac Disease and inflammatory bowel conditions
• Severe systemic bacterial infections and sepsis
• Psoriasis and other chronic inflammatory dermatological conditions

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are critical for effective clinical management. The ADENOSINE DE AMINASE ADA – (SERUM) test is processed daily using fully automated, high-throughput analyzers to ensure rapid and precise reporting. The standard turnaround time (TAT) for this test is typically within 12 to 24 hours from the time of sample collection. Patients receive an automated SMS notification as soon as their diagnostic report is finalized and signed off by a consultant pathologist. Reports can be easily accessed and downloaded online through the secure patient portal on the official Dr. Essa Lab website, via our dedicated mobile application, or collected physically from any of our conveniently located diagnostic centers across Karachi and other major cities.

ADENOSINE DE AMINASE ADA – (SERUM) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Serum Adenosine Deaminase (ADA) Level	Typically < 15 – 25 U/L (varies slightly by age and specific laboratory assay)	Elevated levels (> 25 U/L) indicating immune activation, infection, or hepatic damage; extremely low levels indicating genetic immunodeficiency (SCID).
T-Lymphocyte Activity Indicator	Basal enzymatic activity reflecting a balanced, non-stimulated immune state	Increased activity reflecting robust cell-mediated immune response to intracellular pathogens or autoimmune triggers.
Hepatocellular Integrity Marker	Normal systemic enzyme levels with no active hepatic parenchymal leakage	Elevated serum levels secondary to hepatocyte necrosis, acute hepatitis, or progressive liver cirrhosis.
Mycobacterial Infection Screening	Low baseline levels; low probability of active systemic mycobacterial infection	Significantly elevated levels supporting a clinical diagnosis of active pulmonary or extrapulmonary tuberculosis.
Autoimmune Activity Assessment	Stable enzymatic levels indicating quiescent or controlled autoimmune status	Fluctuating or elevated levels corresponding to active inflammatory phases of rheumatoid arthritis or SLE.
Lymphoproliferative Screening	Normal lymphocyte turnover and metabolic activity	Marked elevations associated with rapid cell division in leukemias and lymphomas.
Immunodeficiency Evaluation	Presence of functional ADA enzyme within normal reference limits	Near-zero or completely absent enzyme activity, diagnostic of autosomal recessive Severe Combined Immunodeficiency (SCID).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for ADENOSINE DE AMINASE ADA – (SERUM)?

• Legacy of Trust: Serving patients and the medical community since 1987 with uncompromised diagnostic accuracy.
• ISO Certified Excellence: Operating under strict ISO 9001:2015 quality management standards to ensure international-grade reporting.
• Expert Pathologists: Reports are reviewed and signed off by highly qualified, experienced consultant pathologists.
• Advanced Technology: Utilizing state-of-the-art, fully automated chemistry and immunology analyzers for precise enzymatic measurements.
• Convenient Home Sample Collection: Professional and hygienic blood collection services at your doorstep across Karachi and other regions.
• Rapid Turnaround Time: Efficient laboratory workflows ensure that accurate results are delivered within 12 to 24 hours.
• Seamless Digital Access: Easy online report retrieval via our secure website portal, SMS links, and user-friendly mobile app.
• Patient-Centric Care: Dedicated to providing a comfortable, professional, and compassionate testing environment at all diagnostic centers.